1Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders: Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002 [J]. MMWR Surveill Sumrn, 2007, 56: 12-28.
2Ghanizadeh A. A preliminary study on screening prevalence of pervasive developmental disorder in school children in Iran [J]. J Autism Dev Disord, 2008, 38: 759-763.
3Geier DA, Geier MR. A prospective study of mercury toxicity biomarkers in autistic spectrum disorders [J]. J Toxicol Environ Health A, 2007, 70: 1723-1730.
4Thompson WW, Price C, Goodson B, et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years [J]. N Engl J Med, 2007, 357: 1281-1292.
5Ng DK, Chan CH, Soo MT, et al. Low-level chronic mercury exposure in children and adolescents: meta-analysis [J]. Pediatr Int, 2007, 49: 80-87.
6Bcrman RF, Pessah IN, Mouton PR, et al. Low level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SIL mice [Jl. Toxicol Sci, 2008, 101: 294-309.
7Miles JH, Takahashi TN. Lack of association between RH status. Rh immune globulin in pregnancy and autism [J]. Am J Med Genet A, 2007, 143: 1397-1407.
8Szatmari P, Paterson AD, Zwaigenbaum L, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements [J]. Nat Genet, 2007, 39: 319-328.
9Ullmann R, Turner G, Kirchhoff M, et al. Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation [J]. Hum Mutat, 2007, 28: 674-682.
10Dimitropoulos A, Schultz RT. Autistic-like symptomatology in Prader-WiUi syndrome: a review of recent findings [J]. Curr Psychiatry Rep, 2007, 9: 159-164.
3Sharma A, Shaw SR. Efficacy of risperidone in managing maladap- rive behaviors for children with autistie spectrum disorder: a me- ta-analysis [J]. J Pediatr Health Care, 2012, 26(4): 291-299.
4Aman MG, Mc Dougle C J, et al. Scahill L Medication and parent training in children with pervasive developmental disorders and seri- ous behavior problems: results from a randomized clinical trial [J]. J Am Acad Child Adolesc Psychiatry, 2009, 48(12): 1143-1154.
5陶国泰.儿童少年精神病学[M].第l版.南京:江苏科学技术出版社.1999:123-125.
6Hamilton P J, Campbell NG, Sharma S, et al. Drosophila me- lanogaster: a novel animal model for the behavioral charac- terization of autism-associated mutations in the dopamine transporter gene [J]. Mol Psychiatry, 2013,18(12): 1235.
7Hamilton P J, Campbell NG, Sharma S, et al. De novo muta- tion in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder [J]. Mol Psychia- try,2013,18(12): 1315-1323.
8Azmitia EC, Singh JS, Whitaker-Azmitia PM. Increased se-rotonin axons (immunoreactive to 5-HT transporter) in post- mortem brains from young autism donors [J]. Neuropharma- cology, 2011,60(7-8) : 1347-1354.
9Amen DG, Trujillo M,Newberg A, et al. Brain SPECT Imag- ing in Complex Psychiatric Cases: An Evidence-Based, Un- demtilized Tool [J]. Open Neuroimag J, 2011,5 : 40-48.
10Brunelle F, Bargiacchi A, Chabane N, et al. Brain imagingof infantile autism [J]. Arch Pediatr, 2012, 19(5) : 547-550.
